DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for brachydactyly-syndactyly syndrome — screening already-approved drugs against its 1-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleBrachydactyly-syndactyly syndrome maps to a 1-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for brachydactyly-syndactyly syndrome is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
What the evidence adds up to
The 1987 analysis of 20 congenital syndactyly cases from a hospital in Pune reports that reconstructive surgery restored hand function in more than 90% of patients. No drug treatment is mentioned. The paper describes the types of anomaly, sex incidence, and associated syndromes, but does not provide survival data, response rates, or any molecular or genetic characterisation of the cases.
A 2021 case report describes two neonates with syndromic syndactyly. The first, a 13-day-old female, presented with dysmorphic features including brachydactyly and syndactyly of the second to fourth fingers bilaterally, and was diagnosed with otopalatodigital syndrome. The second, a 10-day-old male, had cleft palate, syndactyly of the left hand, and was diagnosed with orofaciodigital syndrome. The authors note that these syndromes are rare, often go undiagnosed, and that diagnosis is key for management and genetic counselling. No drug treatment, survival data, or response rates are reported.
A 2019 Russian hospital paper states that syndactyly accounts for more than 50% of all congenital hand anomalies, with a frequency of 1 in 2000 to 1 in 4000 live births. It asserts that treatment is most effective in the first two years of life, but provides no quantitative outcomes, no drug data, and no mention of any pharmacological intervention.
No drug is mentioned in any of the three abstracts. There is no evidence for any medical treatment of brachydactyly-syndactyly syndrome. What is missing is any clinical trial of a drug, any molecular target, any patient stratification beyond clinical diagnosis, and any funding for pharmacological research into this group of conditions.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
Clinical Genetics · 1985 · 23 citations
Trismus‐pseudocamptodactyly syndrome in a Japanese family
AbstractA family in which five individuals through three generations were affected with trismus-pseudocamptodactyly syndrome is reported. The propositus, an 8-year-old boy, had a right embedded ear, inability to open the mouth fully, pseudocamptodactyly and soft tissue syndactyly of the toes. His paternal grandmother, father, paternal uncle and his paternal cousin had pseudocamptodactyly. The occurrence of the syndrome in this Japanese family indicates that the syndrome is not exclusively of Dutch origin.
Indian Journal of Plastic Surgery · 1987 · 0 citations · open access
Congenital Syndactyly: An Analysis of 20 Cases*
AbstractSummary 20 cases of congenital syndactyly seen during the last 3 ½ year at the Command Hospital, Pune have been analysed, elucidating the types of the anomaly confronted, the sex incidence and the associated anomalies / syndromes. The reconstructive procedures performed on these patients are being presented whereby restoration of hand function was achieved in more than 90% of the cases.
International Journal of Recent Surgical and Medical Sciences · 2021 · 0 citations · open access
Two Rare Syndromic Syndactyly Cases in Neonates
AbstractAbstract Introduction Isolated findings of syndactyly are benign. However, syndactyly can be associated with rare syndromes that need to be diagnosed for further management and for genetic counseling. Methods We present two cases of syndromic syndactyly in neonates. The first case is a 13-day-old female neonate with dysmorphic features. The neonate had clinical features of prominent forehead, hypertelorism, widely separated sagittal and metopic sutures, down-slanting eyes, low set ears, depressed nasal bridge, micrognathia, cleft palate, pectus excavatum, brachydactyly, and syndactyly of the second to fourth fingers bilaterally in upper limbs and in lower limbs. The second case is a 10-day-old male neonate with dysmorphism in the form of cleft alveolar ridge and palate, hyperplastic frenula, hypoplastic alar cartilage, syndactyly of the left hand, clinodactyly of the left lower limb toes, and amniotic bands. Discussion Case 1 was diagnosed as otopalatodigital syndrome because of the characteristic clinical features. This is a rare syndrome associated with syndactyly that often goes undiagnosed. Otopalatodigital syndrome spectrum disorders comprise of four phenotypically related conditions: otopalatodigital syndrome types 1 and 2, frontometaphyseal dysplasia, and Melnick–Needles syndrome. As it is associated with x-linked inheritance, its severity is more in males. Case 2 was diagnosed to have orofaciodigital syndrome because of the characteristic clinical features. It is another rare syndrome associated with syndactyly having abnormalities in the development of the oral cavity, face, and digits along with intellectual disability and renal system impairment. Conclusion There are fewer publications on these syndromes as they are rare and diagnosis is difficult. Recognizing these syndromes is key to further management and for genetic counseling.
Archiv Euromedica · 2019 · 0 citations · open access
Experience in the treatment of congenital syndactyly in the Tver Regional Children's Hospital
Abstracta | 2 0 1 9 | v o l . 9 | n u m . 1 | experienCe in the treatment of Congenital syndaCtyly in the tver regional Children's hospital Syndactyly is a congenital malformation, consisting in the fusion of two or more fingers, accompanied by a cosmetic defect and dysfunction of the limb. According to various authors, syndactyly accounts for more than 50% of all congenital anomalies of the hand. The frequency of occurrence is 1: 2000-1: 4000. Treatment of congenital syndactyly is most effective in the first two years of life
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
